2 news items
InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million
INCR
1 May 24
global expansion plans, its expansion strategy to major markets worldwide, statements relating to the security events in Israel, as well as statements
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million
INCR
1 Apr 24
expansion plans, the expected annualized revenue for 2023, its expansion strategy to major markets worldwide, statements relating to the security events
- Prev
- 1
- Next